G. Atalay
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Fátima Cardoso (6 shared papers)Ahmad Awada (3 shared papers)M. Piccart (2 shared papers)Martine Piccart (5 shared papers)Laura Biganzoli (5 shared papers)Tanja Čufer (3 shared papers)Robert Paridaens (3 shared papers)Teresa Gamucci (2 shared papers)
- Journals
- European Journal of Cancer (3 papers)Annals of Oncology (2 papers)International Journal of Gynecological Cancer (2 papers)Anti-Cancer Drugs (1 paper)International Journal of Clinical Oncology (1 paper)
- Partner nations
- BelgiumSloveniaUnited Kingdom
In The Last Decade
G. Atalay
11 papers receiving 306 citations
Peers
Comparison fields: 5 of 57
- Oncology 182
- Cancer Research 82
- Hepatology 40
- Reproductive Medicine 26
- Genetics 82
Countries citing papers authored by G. Atalay
This map shows the geographic impact of G. Atalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Atalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Atalay more than expected).
Fields of papers citing papers by G. Atalay
This network shows the impact of papers produced by G. Atalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Atalay. The network helps show where G. Atalay may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Atalay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 87 | |
| 2 | 2003 | 83 | |
| 3 | 2004 | 70 | |
| 4 | The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. | 2005 | 25 |
| 5 | 2004 | 18 | |
| 6 | 2002 | 10 | |
| 7 | 2003 | 10 | |
| 8 | 2004 | 6 | |
| 9 | 2003 | 4 | |
| 10 | 2002 | 3 | |
| 11 | Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era | 2002 | 1 |
| 12 | 2022 | 0 |
About G. Atalay
G. Atalay is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 12 papers that have together received 317 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Estrogen and related hormone effects (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Breast Cancer Treatment Studies (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Hermeneutics and Narrative Identity (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (182 citations), Cancer Research (82 citations), Hepatology (40 citations), Reproductive Medicine (26 citations) and Genetics (82 citations). G. Atalay has collaborated with scholars based in Belgium, Slovenia and United Kingdom. Frequent co-authors include Fátima Cardoso, Ahmad Awada, M. Piccart, Martine Piccart, Laura Biganzoli, Tanja Čufer, Robert Paridaens, Teresa Gamucci, Françoise Renard and A H Calvert. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, International Journal of Gynecological Cancer, Anti-Cancer Drugs and International Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.